Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity

NCT06756061 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

GVHD - Graft-Versus-Host Disease
Neoplasms
Haematopoietic Stem Cell Transplantation

Interventions

DRUG: Prednisone + Jakavi(ruxolitinib)
DRUG: Prednisone

Sponsor

Byung-Sik Cho

Collaborators

[object Object]